Search
for
Sort by
Research 121–150 of 995
- “Cold” X5 Hairlaser™ used to treat male androgenic alopecia and hair growth: an uncontrolled pilot study
- New lifestyle drugs and somatoform disorders in dermatology
- Severe and Fatal Phenobarbitone Eruptions
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Hair loss with levetiracetam in five patients with epilepsy
- Hirsutism and virilization
- Carbamazepine-Induced Hair Loss
- Chemistry, biological activities and toxic effects of alkaloidal constituents of genus Delphinium - A mini review
- The association between melasma and iron profile: a case-control study
- Drug eruptions in dermatology
- Fatal Toxic Epidermal Necrolysis Associated with Minoxidil
- The effects of topical diazoxide on hair follicular growth and physiology of the stumptailed macaque
- Progestogens in menopausal hormone therapy
- The effect of minocycline on the metabolism of androgens by human oral periosteal fibroblasts and its inhibition by finasteride
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Hyperactivity and alopecia associated with ingestion of valproic acid in a cat
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- A falling out following minoxidil: Telogen effluvium
- Current concepts in the pathogenesis and treatment of acne
- Pharmacokinetic Interaction of Finasteride With Tamsulosin Hydrochloride: An Open-label, Randomized, 3-period Crossover Study in Healthy Chinese Male Volunteers
- An overview of management of drug-induced hair and nail disorders
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Biology of the skin and dermatological disease
- Adverse cutaneous effects of psychotropic medications
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Alopecia and hirsutism*
- Endocrine evaluation of hirsutism
- A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases